Nov 26, 2019Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha RaAlpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Sep 4, 2019Alpha Tau Medical Appoints Jefferson University Radiation Oncologist Robert Den as Chief Medical OffAlpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy Alpha DaRT, announced today the appointment of Dr. Robert...
Nov 26, 2018Israeli Company Set To Begin Testing New Radiation Cancer TherapyAn Israeli medical technology company is set to begin testing its new radiation cancer therapy in leading medical centers in Italy. The...
Nov 7, 2018Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza andTrials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...